<DOC>
	<DOCNO>NCT02278874</DOCNO>
	<brief_summary>The objective clinical study demonstrate accuracy proprietary algorithm method determine genetic health develop fetus multiple gestation pregnancy maternal blood sample . The long term goal study development method minimally invasive prenatal diagnosis high sensitivity lower false positive rate intend population ( e.g . multiple gestation pregnancy ) currently available screen test . This result few unnecessary amniocentesis CVS procedure , associate risk miscarriage .</brief_summary>
	<brief_title>High Risk Multiple Gestation Study</brief_title>
	<detailed_description />
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Chromosome Aberrations</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<mesh_term>Sex Chromosome Aberrations</mesh_term>
	<criteria>Age 18 old enrollment Clinically confirm multiple gestation pregnancy Pregnancy high risk genetic aneuploidy define : Confirmed positive aneuploidy invasive test Non invasive prenatal test `` high risk '' result Serum screening risk great 1:100 Ultrasound abnormality indicative aneuploidy Structural abnormality posterior fossa Holoprosenencephaly Structural cardiac anomaly Omphalocele Nuchal translucency great equal 3.5 mm nuchal fold great Hydrops unknown etiology Age ≥ 38 year delivery ( serum screen risk le 1:100 ) Gestational age ≥ 9 week , 0 day ≤26 week 0 day best obstetrical estimate Able provide inform consent Women carry singleton pregnancy Surrogate egg donor use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Trisomy 13</keyword>
	<keyword>Trisomy 18</keyword>
	<keyword>Trisomy 21</keyword>
	<keyword>Sex Chromosome Abnormalities</keyword>
	<keyword>Monosomy X</keyword>
	<keyword>XXX</keyword>
	<keyword>XXY</keyword>
	<keyword>XYY</keyword>
</DOC>